MAPK1 and cancer: It highlights EMT‐induced radioresistance regulators, such as TGF‐β, Wnt, Notch, ERK, and various miRNAs, as well as therapeutic strategies, including immune checkpoint inhibitors, immune modulators, and cancer therapies.